Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
September 2017
NCT00557193Uploaded 01-12-2024
Access via NCI by Request
PDS UID: nci-data-530
A Phase III Study of Risk Directed Therapy for Infants With Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; NSC#617807)
Files: NCT00557193-D1
Data DictionaryNCT00557193-D1-Data-Dictionary_0.pdf
Files: NCT00557193-D2
Data DictionaryNCT00557193-D2-Data-Dictionary_0.pdf
Files: NCT00557193-D3
Data DictionaryNCT00557193-D3-Data-Dictionary_0.pdf
Files: NCT00557193-D4
Data DictionaryNCT00557193-D4-Data-Dictionary.pdf